SensoDetect operates in the healthcare sector. The company specializes in developing medical equipment that is used to analyze how a patient's brain reacts to sound stimuli. The technology is used in psychiatry to distinguish potential mental illnesses. The product consists of electrodes that are attached to the patient's head and then analyze brain activity. The results are compared against a database for further analysis. SensoDetect was founded in 2005 and is headquartered in Lund.

Quotes for SensoDetect AB

Right Now

+/-
-0.0018
%
−3,52%
Latest
0.0494
High
0.0568
Low
0.0486
Volume
1 025 527
Turnover (SEK)
50 973
Market Value (MSEK)
21,8
Time (Latest trade)

Board

CEO

  • Per-Anders Hedin

Chairperson of the Board

  • Vakans

Board

  • Wendi Ma
  • Articles of association

    • News

    Show More

    News agencies

    Show More

    Analysis

    Videos

    SensoDetect - Stora Aktiedagarna Stockholm 28 november 2024

    SensoDetect

    SensoDetect - Presentation BioStock Live - 2018-11-27

    SensoDetect AB intervju

    Largest Owners

    Name Capital % Votes % Date
    Thomas Erik Frithiof Holmgren Dödsbo 10,20 10,20 2025-12-23
    Nordnet Pensionsförsäkring 8,04 8,04 2025-12-23
    Nowo Fund Management AB 6,60 6,60 2025-12-31
    Avanza Pension 3,84 3,84 2025-12-23
    Karl Vilhelm Gustaf Lundin 3,56 3,56 2025-12-23
    Tore Robertsson 3,14 3,14 2025-12-23
    Johan Möllerström med bolag 3,05 3,05 2025-12-23
    Per-Anders Hedin 2,96 2,96 2025-07-07
    Anna Caroline Holmgren 2,26 2,26 2025-12-23
    Joachim Runesson 2,23 2,23 2025-12-23
    ** Powered by Modular Finance

    Upcoming reports

    • 2026-02-19 Extraordinary General Meeting 2025

    • 2026-02-27 Year End Report 2025

    • 2026-05-22 Annual General Meeting 2025

    Annual reports, prospectus etc.